Hemexdx Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 37.19%
- Profit Growth 30.94%
- Ebitda 39.09%
- Net Worth 79.21%
- Total Assets 111.36%
About Hemexdx
Hemexdx Private Limited (HPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 15 May 2018 (Six years and eight months 26 days old ). Its registered office is in Mumbai, Maharashtra.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Prashant Khadke, Mohan Uttarwar, Amrish Mehta, and One other member serve as directors at the Company.
Company Details
-
LocationMumbai, Maharashtra
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33309MH2018PTC377201
-
Company No.
113130
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 May 2018
-
Date of AGM
24 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Hemexdx?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Khadke
|
Managing Director | 09-Jun-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Patricia Seminario
|
Director | 30-May-2018 | Current |
|
Mohan Uttarwar
|
Director | 14-Jul-2018 | Current |
|
Amrish Mehta
|
Director | 30-May-2018 | Current |
Financial Performance of Hemexdx.
Hemexdx Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.19% increase. The company also saw a substantial improvement in profitability, with a 30.94% increase in profit. The company's net worth Soared by an impressive increase of 79.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hemexdx?
In 2023, Hemexdx had a promoter holding of 100.00% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Indx Technology (India) Private LimitedMohan Uttarwar is a mutual person
-
Dr Amrish Mehta's Apple Diagnostics LlpAmrish Mehta is a mutual person
-
Amhd Healthcare Llp
Amrish Mehta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hemexdx?
Hemexdx has a workforce of 0 employees as of May 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hemexdx, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemexdx's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
